Agilent Technologies, Inc. (LON:0HAV)

Market Cap	27.66B -16.7%
Revenue (ttm)	5.29B +6.7%
Net Income	992.08M +1.1%
EPS	3.48 +3.2%
Shares Out	n/a
PE Ratio	27.88
Forward PE	22.52
Dividend	0.75 (0.56%)
Ex-Dividend Date	Jan 6, 2026

Volume	43
Average Volume	794
Open	129.83
Previous Close	132.56
Day's Range	129.83 - 133.60
52-Week Range	96.93 - 161.56
Beta	1.29
RSI	38.88
Earnings Date	Feb 27, 2026

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 18,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0HAV

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Financial numbers in USD